Skip to main content

Tower Bridge Advisors

SEC CIK
0001278249
Latest filing
Aug 12, 2026

KBLB holding history

Kraig Biocraft Laboratories, Inc. in every 13F filed by Tower Bridge Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KBLB overviewAll 13F holders of KBLBFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of KBLB by Tower Bridge Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−100,000−100.0%Sold outHolders
Q3 2023100,000$3.13K<0.1%+100,000NewHolders
Q2 20230$00.0%−100,000−100.0%Sold outHolders
Q1 2023100,000$4.50K<0.1%00.0%UnchangedHolders
Q4 2022100,000$3.10K<0.1%00.0%UnchangedHolders
Q3 2022100,000$4.61K<0.1%00.0%UnchangedHolders
Q2 2022100,000$5.85K<0.1%00.0%UnchangedHolders
Q1 2022100,000$8.50K<0.1%00.0%UnchangedHolders
Q4 2021100,000$8.40K<0.1%00.0%UnchangedHolders
Q3 2021100,000$8.75K<0.1%00.0%UnchangedHolders
Q2 2021100,000$11.6K<0.1%00.0%UnchangedHolders
Q1 2021100,000$15.2K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.